Pregled bibliografske jedinice broj: 80711
Methyl 2-(2-chloroethylaminocarbonyl)diazenecarboxylate SB-166 inhibits the growth of different tumor cell lines, including drug-resistant sublines
Methyl 2-(2-chloroethylaminocarbonyl)diazenecarboxylate SB-166 inhibits the growth of different tumor cell lines, including drug-resistant sublines // Toxicology in Vitro, 17 (2003), 2; 159-165 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 80711 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Methyl 2-(2-chloroethylaminocarbonyl)diazenecarboxylate SB-166 inhibits the growth of different tumor cell lines, including drug-resistant sublines
Autori
Čimbora, Tamara ; Bombek, Sergeja ; Polanc, Slovenko ; Osmak, Maja
Izvornik
Toxicology in Vitro (0887-2333) 17
(2003), 2;
159-165
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Anticancer drugs; Diazenecarboxamides; Diazenedicarboxamides; Glutathione; Drug-resistance
Sažetak
Recently we synthesized new drugs diazenecarboxamides (shortly diazenes) that were cytotoxic for several tumour cell lines. Because the solubility and biological activity of these drugs was relatively low, new compounds have been synthesized. In the present study we examined the cytotoxic effect of nine compounds: an imidazolidin-2-one (SB-282: methyl 5-benzoyl-3-(2-chloroethyl)-2-oxo-4-phenyl-2, 3-dihydro-1H-imidazol-1-ylcarbamate), two diazenecarboxamides (UP-140: N-phenyl-2-(2-quinolinyl)diazenecarboxamide ; JK-1090: N-(4-iodophenyl)-2-(2-pyridinyl)diazenecarboxamide), two aminocarbonyl substituted diazenecarboxylates (SB-178: methyl 2-[(cyclohexylamino)carbonyl]diazenecarboxylate ; SB-166: methyl 2-{; ; [(2-chloroethyl)amino]carbonyl}; ; diazenecarboxylate) and four diazenedicarboxamides (SB-410: N1-(2-chloroethyl)-N2-(2-pyridinylmethyl)-1, 2-diazenedicarboxamide ; SB-472: N1-(2-chloroethyl)-N2-(4-isopropylphenyl)-1, 2-diazenedicarboxamide ; SB-503: N1-(4-sec-butylphenyl)-N2-(2-chloroethyl)-1, 2-diazenedicarboxamide ; SB-474: N1-(4-tert-butylphenyl)-N2-(2-chloroethyl)-1, 2-diazenedicarboxamide). Using a modified colorimetric MTT assay, their cytotoxicity was determined on eight human cell lines: laryngeal carcinoma parental and two drug-resistant cell lines, glioblastoma parental and drug-resistant cell lines, cervical carcinoma parental and drug-resistant cell lines and breast adenocarcinoma cells. Results show that diazene SB-166 was very effective, reducing significantly the cell survival of all eight examined cell lines, including four drug-resistant cell lines. Compound SB-410 was cytotoxic for all examined cell lines, but mostly only in the highest concentration. Other compounds were not significantly cytotoxic to any of the treated cell lines. Our results, especially those obtained on drug-resistant cells, encourage further research on compound SB-166 as a potential anticancer drug.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE